igorbandeira.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025

submitted 9 days ago • 1 comment

First prize for Best Poster Presentation at the Winter Conference on Brain Research 2025! This recognition is a reminder that perseverance pays off, even in challenging times. Proud and grateful! #WCBR #WCBR2025

submitted 17 days ago • 0 comments

I’m Still Here is a raw and unconventional exploration of identity, struggle, and reinvention. It reminds us that pain and adversity, rather than breaking us, can serve as catalysts for transformation.

submitted 19 days ago • 1 comment

Attending the Winter Conference on Brain Research as a Travel Fellowship Awardee was an incredible opportunity to exchange ideas with peers across preclinical and clinical research. #WCBR #WCBR2025

submitted 24 days ago • 1 comment

Happy to be in beautiful Tahoe as a Travel Fellowship Awardee at the Winter Conference on Brain Research! If you're curious about interventional psychiatry, the opioid properties of #ketamine, and treatment-resistant #depression, stop by my poster tomorrow (Board #31)! #WinterBrain #WCBR2025

submitted 31 days ago • 0 comments

The NIH diversity supplement pages have all been pulled down. What is a diversity supplement and why should the public care? A diversity supplement is funding to help diversify the research workforce. You may be wondering, “so what?”. Let me explain. www.nigms.nih.gov/Pages/PageNo...

submitted 33 days ago • 9 comments

Feeling deeply grateful after an incredible #ACNP2024! It was an honor to connect with inspiring colleagues, foster new connections, and reunite with lifelong friends. Special thanks to the #TravelAward2024 program for the invaluable mentorship and support. @acnporg.bsky.social

submitted 76 days ago • 2 comments

Our poster T16 on #ketamine for suicidal behavior in treatment-resistant #depression is up now at #ACNP2024! Let's discuss the comparative analysis of antisuicidal and antidepressant effects!

submitted 79 days ago • 0 comments

Attending the recent panel on #suicideprevention at #ACNP2024 was truly thought-provoking. The dedication, innovative research, and shared commitment underscore the urgent need to advance effective interventions for this critical public health issue. @acnporg.bsky.social

submitted 79 days ago • 0 comments

Hey #ACNP2024! Grateful to return for my 2nd year, this time as a Travel Awardee! I’m a postdoc at Stanford, working on interventional psychiatry clinical trials with #BrainStimulation and #Ketamine for depression. Hope to see you at my poster (T16) on 12/10!

submitted 82 days ago • 1 comment

Honored to be part of this incredible group of travel awardees. #ACNP2024 #TravelAward2024

submitted 84 days ago • 1 comment

I am thrilled to announce that I have been honored with a Travel Fellowship Award to attend the 2025 Winter Conference on Brain Research!

submitted 92 days ago • 1 comment

Recruitment is ongoing for our study titled "Opiate Suicide Study in Patients with Major Depression" at Stanford University, sponsored by the American Foundation for Suicide Prevention.

submitted 101 days ago • 1 comment

Excited to share that our paper, demonstrating how early changes in lassitude can predict response to Stanford Neuromodulation Therapy in treatment-resistant depression, has been published in npj Mental Health Research, part of the @natureportfolio.bsky.social. www.nature.com/articles/s44...

submitted 121 days ago • 0 comments

Beyond happy to share that I am one of the recipients of the American College of Neuropsychopharmacology 2024 Travel Awards! Grateful to my mentors and colleagues who inspired me on this journey and provided valuable feedback on my application. #ACNP2024

submitted 217 days ago • 0 comments

Honored to announce that I've joined the editorial board of Springer Nature's BMC Psychiatry! Proud to support the dissemination of impactful research in mental health. bmcpsychiatry.biomedcentral.com/about/editor...

submitted 231 days ago • 0 comments

Thrilled to attend the #ASCP2024 this past week as a New Investigator Awardee! The experience was invaluable, from building a network of mentors beyond my Stanford community to receiving helpful feedback on our preliminary data presentation.

submitted 267 days ago • 0 comments

Excited to be at my first American Society of Clinical #Psychopharmacology Annual Meeting and deeply honored to receive the New Investigator Award (NIA)! Connecting with peers and mentors at the NIA Workshop was incredibly inspiring. Looking forward to the upcoming activities and panels! #ASCP2024

submitted 275 days ago • 0 comments

Sharing the good news that a #ketamine paper I co-authored with the Neuropsychopharmacology Lab (UFBA) in Brazil has been recognized as one of the top 10 most-cited and downloaded in the journal Human Psychopharmacology! #TopCitedArticle #TopDownloadedArticle Link: doi.org/10.1002/hup....

submitted 280 days ago • 0 comments

Yesterday, I attended my first #nerdniteSF and was captivated by @nkwhiteman.bsky.social’s talk on his new book, Most Delicious Poison, which explores nature’s toxins and why we are attracted—and addicted—to them. Can’t wait to read it!

submitted 280 days ago • 0 comments

I had such an incredible experience at #SOBP2024! 🧠 More than just a conference, it was a chance to reconnect with old friends and make new connections. Grateful for the opportunity to immerse myself in cutting-edge research and vibrant discussions! #Ketamine #Depression #SuicidePrevention

submitted 289 days ago • 0 comments

Hey #SOBP2024 community! As a Stanford Postdoc, I've worked on #brainstimulation and #ketamine clinical trials for treatment-resistant #depression. Look out for my poster presentation (F151) tomorrow. I'm eager to connect with fellow researchers and share our data.

submitted 294 days ago • 0 comments

Feeling privileged to have been a travel awardee at the American Society of Hispanic #Psychiatry Annual Meeting in NYC! Sharing preliminary results from our AFSP funded trial on #ketamine / buprenorphine for suicide behavior and fostering invaluable connections was truly amazing. #APAAM24

submitted 296 days ago • 0 comments

19th Annual Mood Disorders Education Day Saturday, October 14, 2023 9:00 AM – 1:00 PM (PT) Translating Emerging Treatments for Mood Disorders Into Practice t.co/QwGV32vAgH

submitted 505 days ago • 0 comments

Proud to share my latest first authorship! This is the first clinical trial testing IV arketamine for bipolar depression. Subjects received two infusions one week apart—0.5 mg/kg first and then 1 mg/kg, showing rapid-acting antidepressant properties. https://doi.org/10.1016/j.jpsychires.2023.06.028

submitted 603 days ago • 1 comment